USA • New York Stock Exchange • NYSE:ABBV • US00287Y1091
Overall ABBV gets a fundamental rating of 5 out of 10. We evaluated ABBV against 523 industry peers in the Biotechnology industry. There are concerns on the financial health of ABBV while its profitability can be described as average. ABBV is cheap, but on the other hand it scores bad on growth. Finally ABBV also has an excellent dividend rating.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.75% | ||
| ROE | N/A | ||
| ROIC | 15.64% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.05% | ||
| PM (TTM) | 3.94% | ||
| GM | 71.16% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.49 | ||
| Altman-Z | 2.42 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.72 | ||
| Quick Ratio | 0.6 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.24 | ||
| Fwd PE | 15.32 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.97 | ||
| EV/EBITDA | 16.23 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.1% |
222.44
-0.82 (-0.37%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.1% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.24 | ||
| Fwd PE | 15.32 | ||
| P/S | 6.59 | ||
| P/FCF | 19.97 | ||
| P/OCF | 18.85 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 16.23 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.75% | ||
| ROE | N/A | ||
| ROCE | 20.86% | ||
| ROIC | 15.64% | ||
| ROICexc | 16.59% | ||
| ROICexgc | 572.43% | ||
| OM | 33.05% | ||
| PM (TTM) | 3.94% | ||
| GM | 71.16% | ||
| FCFM | 33% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.49 | ||
| Debt/EBITDA | 2.39 | ||
| Cap/Depr | 14.25% | ||
| Cap/Sales | 1.97% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.59% | ||
| Profit Quality | 838.33% | ||
| Current Ratio | 0.72 | ||
| Quick Ratio | 0.6 | ||
| Altman-Z | 2.42 |
ChartMill assigns a fundamental rating of 5 / 10 to ABBV.
ChartMill assigns a valuation rating of 8 / 10 to ABBVIE INC (ABBV). This can be considered as Undervalued.
ABBVIE INC (ABBV) has a profitability rating of 6 / 10.
The Price/Earnings (PE) ratio for ABBVIE INC (ABBV) is 22.24 and the Price/Book (PB) ratio is -148.8.
The Earnings per Share (EPS) of ABBVIE INC (ABBV) is expected to grow by 45.22% in the next year.